Successful resolution of pneumonia developed in a patient affected by Crohn's disease, rheumatoid arthritis, myasthenia gravis and recurrent uveitis during concomitant treatment with tumour necrosis factor alpha inhibitors and conventional immunosuppressive drugs.
Rheumatol Int
; 30(7): 977-8, 2010 May.
Article
em En
| MEDLINE
| ID: mdl-19551384
Tumour necrosis factor alpha inhibitors, both infliximab and adalimumab, have been approved for the treatment of both rheumatoid arthritis and Crohn's disease. A slight increase in the risk of infections in patients receiving immunosuppressants and/or biological agents has been reported. Here, we present the case of a 68-year-old woman affected by Crohn's disease, myasthenia gravis, recurrent uveitis and rheumatoid arthritis who developed pneumonia during concomitant treatment with biological agents and conventional immunosuppressive drugs.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Pneumonia
/
Doenças Autoimunes
/
Fator de Necrose Tumoral alfa
/
Hospedeiro Imunocomprometido
/
Antirreumáticos
/
Imunossupressores
Limite:
Aged
/
Female
/
Humans
Idioma:
En
Ano de publicação:
2010
Tipo de documento:
Article